(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Purity ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

Kufotokozera Kwachidule:

Dzina Lamankhwala: (S)-(+)-Glycidyl Phthalimide

CAS: 161596-47-0

Maonekedwe: Ufa Woyera mpaka Woyera

Kuyera: ≥98.0% (HPLC)

Pakati pa Rivaroxaban (CAS: 366789-02-8) pochiza Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

Titumizireni imelo

Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Manufacturer Supply Rivaroxaban Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-imodzi CAS 438056-69-0
Rivaroxaban Wapakatikati CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Chemical Properties:

Dzina la Chemical	(S)-(+)-Glycidyl Phthalimide
Mawu ofanana ndi mawu	(S)-Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;Rivaroxaban Intermediate
Nambala ya CAS	161596-47-0
Nambala ya CAT	Chithunzi cha RF-PI128
Stock Status	Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula	C11H9NO3
Kulemera kwa Maselo	203.19
Melting Point	102 ℃
Mtundu	Ruifu Chemical

Zofotokozera:

Kanthu	Zofotokozera
Maonekedwe	Ufa Woyera mpaka Woyera
Chizindikiritso	Mtengo wa HPLC
Kutaya pa Kuyanika	≤0.50%
Sulphate Ash	≤0.50%
Kuyera / Kusanthula Njira	≥98.0% (HPLC)
Phthalimide	≤0.10%
Single Max Impurity	≤0.50%
Zonse Zonyansa	≤2.0%
Epichlorohydrin	≤0.10%
Glycidol	≤0.10%
Chiral Purity	R-isomer ≤2.0% (HPLC)
Test Standard	Enterprise Standard
Kugwiritsa ntchito	Rivaroxaban (CAS: 366789-02-8) Wapakatikati

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route

Phukusi & Kusungira:

Ubwino:

FAQ:

Ntchito:

Shanghai Ruifu Chemical Co., Ltd. ndi omwe amapanga ndi kugulitsa (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) ndi apamwamba kwambiri.Ndiwopakatikati mwa kaphatikizidwe ka Rivaroxaban (CAS: 366789-02-8), pochiza Venous Thromboembolism (VTE).

Rivaroxaban (Xarelto; CAS: 366789-02-8) ndi mankhwala a antithrombotic ndipo adapangidwa mogwirizana pakati pa kampani ya German Bayer Pharmaceuticals ndi American Johnson.Rivaroxaban asonyezedwa zochizira zakuya mtsempha thrombosis ndi m`mapapo mwanga embolism, ndi kupewa mobwerezabwereza zakuya thrombosis ndi m`mapapo mwanga embolism akuluakulu.